WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Synaptic Systems Antibody Company
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (136)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vanderschuren, L. J. M. J.
Right arrow Articles by Schoffelmeer, A. N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vanderschuren, L. J. M. J.
Right arrow Articles by Schoffelmeer, A. N. M.

 Previous Article  |  Next Article 

The Journal of Neuroscience, November 1, 1999, 19(21):9579-9586

A Single Exposure to Amphetamine Is Sufficient to Induce Long-Term Behavioral, Neuroendocrine, and Neurochemical Sensitization in Rats

Louk J. M. J. Vanderschuren, E. Donné Schmidt, Taco J. De Vries, Caroline A. P. Van Moorsel, Fred J.H. Tilders, and Anton N. M. Schoffelmeer

Research Institute Neurosciences Vrije Universiteit, Department of Pharmacology, Medical Faculty, Free University, 1081 BT Amsterdam, The Netherlands

Repeated treatment with psychostimulant drugs causes long-lasting behavioral sensitization and associated neuroadaptations. Although sensitization induced by a single psychostimulant exposure has also been reported, information on the behavioral and neurochemical consequences of a single psychostimulant exposure is sparse. Therefore, to evaluate whether behavioral sensitization evoked by single and repeated psychostimulant pretreatment regimens represent the same neurobiological phenomenon, the time-dependent expression of behavioral, neurochemical, and neuroendocrine sensitization after a single exposure to amphetamine was investigated in rats. A single exposure to amphetamine (5 mg/kg, i.p.) caused context-independent sensitization of the locomotor effects of amphetamine, which intensified over time. Thus, sensitization to amphetamine was marginal at 3 d after treatment and more evident after 1 week, whereas 3 weeks after treatment, profound sensitization, as well as cross-sensitization, to cocaine was observed. Amphetamine pretreatment caused an increase in the electrically evoked release of [3H]dopamine from nucleus accumbens, caudate putamen, and medial prefrontal cortex slices and of [14C]acetylcholine from accumbens and caudate slices. The hyperreactivity of dopaminergic nerve terminals appeared to parallel the development of locomotor sensitization, i.e., whereas hyperreactivity of accumbens dopaminergic terminals increased between 3 d and 3 weeks after treatment, the hyperreactivity of medial prefrontal dopaminergic terminals decreased. Pre-exposure to amphetamine also sensitized the hypothalamus-pituitary-adrenal axis response to amphetamine at 1 and 3 weeks, but not at 3 d after treatment. Because these data closely resemble those reported previously for repeated amphetamine pretreatment, it is concluded that a single exposure to amphetamine is sufficient to induce long-term behavioral, neurochemical, and neuroendocrine sensitization in rats.

Key words: amphetamine; locomotor sensitization; dopamine release; acetylcholine release; nucleus accumbens; hypothalamus-pituitary-adrenal axis; caudate putamen; medial prefrontal cortex


Copyright © 1999 Society for Neuroscience  0270-6474/99/19219579-08$05.00/0


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Pastor, C. S. McKinnon, A. C. Scibelli, S. Burkhart-Kasch, C. Reed, A. E. Ryabinin, S. C. Coste, M. P. Stenzel-Poore, and T. J. Phillips
From the Cover: Corticotropin-releasing factor-1 receptor involvement in behavioral neuroadaptation to ethanol: A urocortin1-independent mechanism
PNAS, July 1, 2008; 105(26): 9070 - 9075.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. M. Jutkiewicz, M. G. Baladi, J. E. Folk, K. C. Rice, and J. H. Woods
The {delta}-Opioid Receptor Agonist SNC80 [(+)-4-[{alpha}(R)-{alpha}-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] Synergistically Enhances the Locomotor-Activating Effects of Some Psychomotor Stimulants, but Not Direct Dopamine Agonists, in Rats
J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 714 - 724.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
S. M. McBride and F. W. Flynn
Centrally administered vasopressin cross-sensitizes rats to amphetamine and drinking hypertonic NaCl
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1452 - R1458.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A.-G. Corbille, E. Valjent, G. Marsicano, C. Ledent, B. Lutz, D. Herve, and J.-A. Girault
Role of Cannabinoid Type 1 Receptors in Locomotor Activity and Striatal Signaling in Response to Psychostimulants
J. Neurosci., June 27, 2007; 27(26): 6937 - 6947.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
I. Boileau, A. Dagher, M. Leyton, R. N. Gunn, G. B. Baker, M. Diksic, and C. Benkelfat
Modeling Sensitization to Stimulants in Humans: An [11C]Raclopride/Positron Emission Tomography Study in Healthy Men
Arch Gen Psychiatry, December 1, 2006; 63(12): 1386 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Valjent, A.-G. Corbille, J. Bertran-Gonzalez, D. Herve, and J.-A. Girault
Inhibition of ERK pathway or protein synthesis during reexposure to drugs of abuse erases previously learned place preference
PNAS, February 21, 2006; 103(8): 2932 - 2937.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Valjent, V. Pascoli, P. Svenningsson, S. Paul, H. Enslen, J.-C. Corvol, A. Stipanovich, J. Caboche, P. J. Lombroso, A. C. Nairn, et al.
From The Cover: Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum
PNAS, January 11, 2005; 102(2): 491 - 496.
[Abstract] [Full Text] [PDF]


Home page
Cereb CortexHome page
M. A. Nitsche, J. Grundey, D. Liebetanz, N. Lang, F. Tergau, and W. Paulus
Catecholaminergic Consolidation of Motor Cortical Neuroplasticity in Humans
Cereb Cortex, November 1, 2004; 14(11): 1240 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. A. Kim, K. A. Pollak, G. O. Hjelmstad, and H. L. Fields
A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism
PNAS, April 13, 2004; 101(15): 5664 - 5669.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Pierucci, V. Di Matteo, and E. Esposito
Stimulation of Serotonin2C Receptors Blocks the Hyperactivation of Midbrain Dopamine Neurons Induced by Nicotine Administration
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 109 - 118.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Weinshenker, N. S. Miller, K. Blizinsky, M. L. Laughlin, and R. D. Palmiter
Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals
PNAS, October 15, 2002; 99(21): 13873 - 13877.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. B. Glickstein, P. R. Hof, and C. Schmauss
Mice Lacking Dopamine D2 and D3 Receptors Have Spatial Working Memory Deficits
J. Neurosci., July 1, 2002; 22(13): 5619 - 5629.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Abarca, U. Albrecht, and R. Spanagel
Cocaine sensitization and reward are under the influence of circadian genes and rhythm
PNAS, June 25, 2002; 99(13): 9026 - 9030.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. N. M. Schoffelmeer, T. J. De Vries, G. Wardeh, H. W. M. van de Ven, and L. J. M. J. Vanderschuren
Psychostimulant-Induced Behavioral Sensitization Depends on Nicotinic Receptor Activation
J. Neurosci., April 15, 2002; 22(8): 3269 - 3276.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
T. Nikaido, M. Akiyama, T. Moriya, and S. Shibata
Sensitized Increase of Period Gene Expression in the Mouse Caudate/Putamen Caused by Repeated Injection of Methamphetamine
Mol. Pharmacol., April 1, 2001; 59(4): 894 - 900.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
C. Schmauss
A Single Dose of Methamphetamine Leads to a Long Term Reversal of the Blunted Dopamine D1 Receptor-mediated Neocortical c-fos Responses in Mice Deficient for D2 and D3 Receptors
J. Biol. Chem., December 1, 2000; 275(49): 38944 - 38948.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Yang, C. K. Hwang, E. Junn, G. Lee, and M. M. Mouradian
ZIC2 and Sp3 Repress Sp1-induced Activation of the Human D1ADopamine Receptor Gene
J. Biol. Chem., December 1, 2000; 275(49): 38863 - 38869.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-